GlassScriptPhysician profile
Joseph Laratta
NPI 1346506052
$819,323.65
in general payments reported to CMS, 2019-2025
20 companies · $179K in 2025
The $179K reported for 2025 was more than what 95% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127K · 2020: $93K · 2021: $81K · 2022: $108K · 2023: $102K · 2024: $130K · 2025: $179K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $239K · Royalty Or License: $125K · Travel and Lodging: $38K · Food and Beverage: $9,034 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $239,074.07 |
| Royalty Or License | $124,692.39 |
| Travel and Lodging | $37,500.80 |
| Food and Beverage | $9,033.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $355.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $295,419.75 | 2019-2025 | Perla C, Perla Tl, Juliet Ll |
| Spineart Sa | $125,550.08 | 2019-2025 | Perla Tl - Mis |
| Stryker Corporation | $100,432.88 | 2019-2021 | |
| Providence Medical Technology, INC. | $98,340.72 | 2019-2025 | |
| Si-Bone, INC. | $76,394.70 | 2019-2024 | |
| Evolution Spine, LLC | $45,794.43 | 2019-2025 | Whistler Modular Screw System |
| Alphatec Spine, INC | $40,661.10 | 2022-2025 | Other - Miscellaneous, Battalion Llif, Solus Alif |
| Expanding Innovations, INC. | $14,397.50 | 2025 | X-Pac |
| Nuvasive, INC. | $10,215.91 | 2019-2021 | |
| Medtronic USA, INC. | $7,916.95 | 2019-2020 | |
| Medtronic, INC. | $2,159.51 | 2021-2025 | Unid_pass |
| 4web, INC. | $652.25 | 2019-2020 | |
| Orthofix Medical, INC. | $580.16 | 2021-2024 | Lattus, Regatta Lateral System, Waveform C |
| Nevro Corp. | $374.29 | 2022-2024 | Senza |
| Zimvie INC. | $140.14 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $70.84 | 2019 | |
| Precision Spine, INC. | $69.38 | 2023 | |
| Abbott Laboratories | $63.64 | 2019 | |
| Baxter Healthcare | $59.89 | 2019-2020 | |
| Depuy Synthes Sales INC. | $29.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$28,795.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Laratta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.